Boden says that the Oxford researchers have contacted him about looking to see if any evidence of the side effect can be seen in the data for AIM-HIGH, but would not discuss the results further.
Today, one of Amgen's (nasdaq: AMGN - news - people ) side-effect drugs, Neulasta, is getting a boost as researchers present data at the Multinational Association of Supportive Care in Cancer annual meeting in Miami showing that it can reduce infections brought on by chemotherapy -- and the hospitalizations that result -- by more than 90%.